Cargando…
Diagnostic Utility of Genetic and Immunohistochemical H3-3A Mutation Analysis in Giant Cell Tumour of Bone
To validate the reliability and implementation of an objective diagnostic method for giant cell tumour of bone (GCTB). H3-3A gene mutation testing was performed using two different methods, Sanger sequencing and immunohistochemical (IHC) assays. A total of 214 patients, including 120 with GCTB and 9...
Autores principales: | Wągrodzki, Michał, Tysarowski, Andrzej, Seliga, Katarzyna, Wojnowska, Aneta, Stepaniuk, Maria, Castañeda Wysocka, Patrycja, Makuła, Donata, Pieńkowski, Andrzej, Szostakowski, Bartłomiej, Zub, Renata, Rutkowski, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778699/ https://www.ncbi.nlm.nih.gov/pubmed/35055156 http://dx.doi.org/10.3390/ijms23020969 |
Ejemplares similares
-
Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence
por: Borkowska, Aneta Maria, et al.
Publicado: (2022) -
Denosumab treatment of inoperable or locally advanced giant cell tumor of bone
por: Borkowska, Aneta, et al.
Publicado: (2016) -
Long-term follow-up in adults with extremity osteosarcoma: comparison of different surgical procedures – single-center experience
por: Goryń, Tomasz, et al.
Publicado: (2019) -
Functional outcome of surgical treatment of adults with extremity osteosarcoma after megaprosthetic reconstruction—single-center experience
por: Goryń, Tomasz, et al.
Publicado: (2019) -
Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall: Results of a Single-Arm Prospective Clinical Trial
por: Koseła-Paterczyk, Hanna, et al.
Publicado: (2020)